ProtocolGen generates structured, review-ready protocol drafts from study summaries using template-governed AI, curated clause libraries, ICH M11-aligned structure, TransCelerate CPT-style content organization, collaboration workflows, and human-guided validation.
Regulated research organizations spend significant time and effort creating protocols — even for study types they have executed dozens of times before.
Protocol sections are rewritten from scratch for each study — even when the design, methods, and structure are nearly identical to previous protocols executed by the same team.
Different writers use different wording for similar clauses — creating inconsistency across the organization's protocol library, increasing review effort, and undermining institutional standards.
Multiple stakeholders review protocols sequentially with inconsistent inputs — increasing revision rounds, causing version confusion, and delaying study activation timelines.
Critical study design decisions — sample size assumptions, statistical methods, endpoint definitions — are sometimes made inconsistently or left under-specified in initial protocol drafts.
When experienced protocol writers leave, their knowledge of regulatory nuances, organizational preferences, and proven clause language leaves with them — creating avoidable dependency risk.
Protocol finalization — resolving reviewer comments, tracking open items, managing version history — is managed manually, creating delays at a critical point in the study timeline.
ProtocolGen turns study summaries into structured, review-ready protocol drafts — using controlled AI, curated clause libraries, and governed workflows rather than open-ended generation.
Enter key study parameters — study type, phase, therapeutic area, design, endpoints, population, statistical approach — as structured inputs to guide AI-assisted drafting in context.
AI generates structured protocol section drafts grounded in approved templates and clause libraries — not open-ended text generation — ensuring every draft follows organizational standards.
Select, adapt, and reuse pre-built protocol clauses curated from organizational standards — for inclusion/exclusion criteria, PK sampling, randomization, endpoints, and more.
Automated checks flag structural gaps, missing required sections, and clause inconsistencies across the draft — supporting human reviewers in identifying issues before formal review cycles.
Built-in multi-stakeholder review workflows with inline commenting, markup, version comparison, and role-based approval stages — for controlled, accountable protocol review cycles.
Resolve reviewer comments, close open items, lock approved versions, and generate finalized protocol documents with complete version history and audit trail for regulatory and sponsor submission.
ProtocolGen is designed to support internationally recognized protocol development frameworks — while remaining fully configurable to your organization's own templates and requirements.
International guidance for clinical study protocol content and organization — for globally consistent, regulated trial development.
Modular, clear protocol content structures drawn from TransCelerate Common Protocol Template principles — reducing ambiguity across review teams.
Fully configurable to your approved protocol templates, clause libraries, house style, and study-type standards — every draft reflects your organization.
ProtocolGen adapts to your study type through configurable templates, curated clause libraries, and study design logic tailored to the regulatory and scientific requirements of each research environment.
Bioequivalence and Phase I protocols share a high degree of structural similarity across studies — making them ideal candidates for template-driven AI-assisted drafting at scale. ProtocolGen helps BA/BE centers and Phase I units standardize structure, reuse approved clause libraries, and reduce repetitive drafting effort across high-volume protocol production cycles.
Late phase protocols involve complex scientific design, multi-site operational requirements, and diverse regulatory expectations — creating significant drafting and review effort. ProtocolGen provides structured study design parameter inputs, endpoint-specific clause libraries, and multi-stakeholder review workflows for complex protocol development.
Real-world evidence and observational study protocols require structured designs that reflect complex data sources, diverse populations, and methodological rigor. ProtocolGen supports registry protocols, RWE study designs, and observational research structures with configurable templates and design logic parameters.
Consumer research and nutraceutical claims studies require structured, scientifically rigorous protocols — but typically sit outside traditional pharma protocol processes. ProtocolGen provides configurable templates for consumer study designs, observational registry protocols, and claims substantiation study structures.
Medical device clinical evaluation protocols and diagnostic performance study designs require specific structural and content standards aligned with device regulatory frameworks. ProtocolGen supports device study protocol structures including clinical evaluation, post-market clinical follow-up, and diagnostic accuracy study designs.
ProtocolGen provides medical writers with a structured starting point for protocol drafts — reducing time spent on blank-page drafting and enabling focus on scientific accuracy, regulatory language, and review quality.
Clinical research teams use ProtocolGen to initiate study protocols faster — using organizational templates, approved clause libraries, and study design logic to generate structured drafts for immediate review.
CROs with high-volume protocol production — particularly BA/BE and Phase I-focused organizations — use ProtocolGen to standardize draft quality, reduce per-protocol effort, and manage review workflows at scale.
Pharma clinical development and protocol teams use ProtocolGen to maintain organizational standards, preserve institutional knowledge in templates, and accelerate complex late phase protocol development cycles.
Regulatory professionals use ProtocolGen to review protocol structure and content against ICH M11 and organization-specific standards — with structured outputs that simplify regulatory review and submission preparation.
Biostatisticians review AI-generated statistical methodology sections and sample size rationale in ProtocolGen drafts — contributing to an integrated protocol review workflow with clear accountability and version tracking.
Consumer research and product development teams use ProtocolGen to create structured, scientifically rigorous protocols for claims substantiation, product efficacy, and observational consumer studies.
ProtocolGen is designed to help organizations reduce the cost, effort, and risk associated with protocol development — without replacing the qualified professionals who make final decisions.
Book a focused ProtocolGen demo tailored to your study type — and see how template-governed AI can help your team produce better first drafts, maintain organizational standards, and move through review cycles more efficiently.